Document Basket

Saved pages

Saved documents

Please note: This information is saved in a cookie. In case your browser deletes cookies after a session, the information will be lost.


DKSH markets maqui berry extracts from Anklam Extrakt throughout Europe

DKSH, a leading Market Expansion Services provider, has signed an exclusive agreement to market and distribute Anklam Extrakt’s premium, branded and patented ingredients Delphinol® and MaquiBright® for use in the dietary supplement and functional food industries throughout selected countries in Europe.

Media release

DKSH markets maqui berry extracts from Anklam Extrakt throughout Europe

DKSH, a leading Market Expansion Services provider, has signed an exclusive agreement to market and distribute Anklam Extrakt’s premium, branded and patented ingredients Delphinol® and MaquiBright® for use in the dietary supplement and functional food industries throughout selected countries in Europe.

Milan, Italy, May 3, 2017 – DKSH Business Unit Performance Materials, a leading ingredients and specialty chemicals distributor and provider of Market Expansion Services, and Anklam Extrakt, a leading German manufacturer of natural extracts from plants, vegetables and fruits, have signed an exclusive agreement for DKSH to market and distribute Anklam Extrakt’s branded ingredients Delphinol® and MaquiBright® in all main European markets.  

 

Delphinol® and MaquiBright® are premium, branded and patented extracts of maqui berry, a native berry that only grows in the wild forests of the Patagonian region of Chile and Argentina and are exclusively produced by Anklam Extrakt in Germany. Delphinol® and MaquiBright® are the only extracts of maqui berry providing rich purified flavonoids standardized to bear a minimum of 25% delphinidins and a minimum of 35% total anthocyanins.

 

Delphinol® is at present the only known natural active ingredient which moderates absorption of refined carbohydrates with pure glucose, representing an interesting new component for combination product formulations, dedicated to optimal blood sugar control to include the previously unaddressed glucose.

 

MaquiBright® is currently the sole oral active ingredient which was proven in a first clinical trial to restore tear fluid production in people with dry eye symptoms.

 

Anklam Extrakt has chosen to work with DKSH for its first-class reputation in providing integrated and tailored Market Expansion Services along the entire value chain as well as for its extensive regulatory, distribution and logistics capabilities in the region.

 

Riccardo Giacomessi, Director, Business Line Food & Beverage Industry, Europe, DKSH, commented: “We are very excited to offer Anklam Extrakt’s high-quality branded ingredients to our many customers based throughout Europe. The numerous benefits of these extracts will truly enhance the finished products of food, beverage and nutritional supplement manufacturers. We look forward to a long and prosperous relationship with Anklam Extrakt.”